Literature DB >> 19010834

Clonal evolution in t(14;18)-positive follicular lymphoma, evidence for multiple common pathways, and frequent parallel clonal evolution.

Francesco d'Amore1, Eric Chan, Javeed Iqbal, Huimin Geng, Ken Young, Li Xiao, Michelle M Hess, Warren G Sanger, Lynette Smith, Carsten Wiuf, Oskar Hagberg, Kai Fu, Wing C Chan, Bhavana J Dave.   

Abstract

PURPOSE: Follicular lymphoma typically has acquired a t(14;18) translocation, but subsequent additional cytogenetic abnormalities contribute to disease progression. The main aims of the study are to (a) identify the frequency and temporal sequence of cytogenetic events in t(14;18)-positive follicular lymphoma, (b) determine if there are specific pathways in the evolution of follicular lymphoma, (c) determine the clonal divergence in cases with sequential biopsies or multiple clones from a single biopsy, and (d) determine the association of genetic imbalances with clinical outcome. EXPERIMENTAL
DESIGN: All cases with a histologically confirmed diagnosis of follicular lymphoma and cytogenetic analysis showing t(14;18)(q32;q21) were included. The karyotypes were reviewed and cytogenetic data were entered into a relational database for further computational analysis; 418 biopsies from 360 follicular lymphoma patients including 43 sequential biopsies were analyzed.
RESULTS: Of the cases with only one or two genomic imbalances, the most frequent chromosomal imbalances were +7, del(6q), +der(18)t(14;18), +18, and +X. These abnormalities were also among the most frequent ones encountered when all karyotypes were analyzed. Cytogenetically abnormal clones in the same (26%) and sequential biopsies (63%) often showed divergence of genetic alterations. Balanced translocations other than the t(14;18) were uncommon events, but chromosomal breaks involving 14q32, 18q21, 1p36, 1q21, 10q22, 10q24, and a large cluster at 6q occurred relatively frequently. del(6q), +5, +19, and +20 were associated with poorer overall survival, and del(17p) was associated with poorer event-free survival. Lower-grade tumors (1 and 2) were associated with fewer imbalances.
CONCLUSION: Our analysis suggested that +der(18)t(14;18) may be an entry point to a distinct pathway of genetic evolution in follicular lymphoma. The other common early events appeared to provide multiple entry points, and they might cooperate in the pathogenesis and progression of the follicular lymphoma. Cytogenetically abnormal clones from same patients often showed divergence of genetic alterations, suggesting that parallel evolution from precursor clones are frequent events. This study provides the framework for further analysis of genetic pathways of tumor progression.

Entities:  

Mesh:

Year:  2008        PMID: 19010834     DOI: 10.1158/1078-0432.CCR-08-0752

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  16 in total

1.  Genomic and epigenomic co-evolution in follicular lymphomas.

Authors:  M Loeffler; M Kreuz; A Haake; D Hasenclever; H Trautmann; C Arnold; K Winter; K Koch; W Klapper; R Scholtysik; M Rosolowski; S Hoffmann; O Ammerpohl; M Szczepanowski; D Herrmann; R Küppers; C Pott; R Siebert
Journal:  Leukemia       Date:  2014-07-16       Impact factor: 11.528

Review 2.  Transformation of follicular lymphoma.

Authors:  Izidore S Lossos; Randy D Gascoyne
Journal:  Best Pract Res Clin Haematol       Date:  2011-05-06       Impact factor: 3.020

3.  Detection of chromosomal abnormalities by G-banding and prognostic impact in follicular lymphoma in the rituximab era.

Authors:  Taku Tsukamoto; Miki Kiyota; Eri Kawata; Nobuhiko Uoshima; Shotaro Tatekawa; Yoshiaki Chinen; Hisao Nagoshi; Shinsuke Mizutani; Yuji Shimura; Mio Yamamoto-Sugitani; Tsutomu Kobayashi; Shigeo Horiike; Satoru Yasukawa; Akio Yanagisawa; Masafumi Taniwaki; Junya Kuroda
Journal:  Int J Hematol       Date:  2016-12-19       Impact factor: 2.490

4.  Digital PCR using micropatterned superporous absorbent array chips.

Authors:  Yazhen Wang; Kristopher M Southard; Yong Zeng
Journal:  Analyst       Date:  2016-03-24       Impact factor: 4.616

5.  Increasing genomic and epigenomic complexity in the clonal evolution from in situ to manifest t(14;18)-positive follicular lymphoma.

Authors:  J Schmidt; I Salaverria; A Haake; I Bonzheim; P Adam; S Montes-Moreno; M A Piris; F Fend; R Siebert; L Quintanilla-Martinez
Journal:  Leukemia       Date:  2013-10-23       Impact factor: 11.528

6.  Single-cell multiplex gene detection and sequencing with microfluidically generated agarose emulsions.

Authors:  Richard Novak; Yong Zeng; Joe Shuga; Gautham Venugopalan; Daniel A Fletcher; Martyn T Smith; Richard A Mathies
Journal:  Angew Chem Int Ed Engl       Date:  2011-01-10       Impact factor: 15.336

7.  Dissecting the gray zone between follicular lymphoma and marginal zone lymphoma using morphological and genetic features.

Authors:  Oscar Krijgsman; Patricia Gonzalez; Olga Balagué Ponz; Margaretha G M Roemer; Stefanie Slot; Annegien Broeks; Linde Braaf; Ron M Kerkhoven; Freek Bot; Krijn van Groningen; Max Beijert; Bauke Ylstra; Daphne de Jong
Journal:  Haematologica       Date:  2013-07-12       Impact factor: 9.941

8.  Mutations in linker histone genes HIST1H1 B, C, D, and E; OCT2 (POU2F2); IRF8; and ARID1A underlying the pathogenesis of follicular lymphoma.

Authors:  Hongxiu Li; Mark S Kaminski; Yifeng Li; Mehmet Yildiz; Peter Ouillette; Siân Jones; Heather Fox; Kathryn Jacobi; Kamlai Saiya-Cork; Dale Bixby; Daniel Lebovic; Diane Roulston; Kerby Shedden; Michael Sabel; Lawrence Marentette; Vincent Cimmino; Alfred E Chang; Sami N Malek
Journal:  Blood       Date:  2014-01-16       Impact factor: 22.113

9.  New developments in the pathology of malignant lymphoma: a review of the literature published from August to December 2008.

Authors:  J Han van Krieken
Journal:  J Hematop       Date:  2009-03       Impact factor: 0.196

10.  t(14;18)-negative follicular lymphomas are associated with a high frequency of BCL6 rearrangement at the alternative breakpoint region.

Authors:  Keni Gu; Kai Fu; Smrati Jain; Zhongfen Liu; Javeed Iqbal; Min Li; Warren G Sanger; Dennis D Weisenburger; Timothy C Greiner; Patricia Aoun; Bhavana J Dave; Wing C Chan
Journal:  Mod Pathol       Date:  2009-05-22       Impact factor: 7.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.